It takes an estimated 10-15 years and more than $1 billion to successfully bring a new drug to market today.
Whether you work in a lab or an office, if you want to be successful in this industry, it is critical that you have a thorough understanding of the scientific disciplines required for the discovery, development, and evaluation of new drugs.
Our master’s program in Pharmaceutical Sciences provides precisely this type of education.
Through thesis and non-thesis options, we have created a curriculum with the flexibility to meet the needs of the aspiring research scientist, pharmacist, as well as the working professional looking to advance their career in the biomedical or pharmaceutical industry. Albany College of Pharmacy and Health Sciences is a top choice for Pharmaceutical Sciences colleges.
The program includes a variety of required and elective courses that allow students to achieve individual academic goals, in the context of either a thesis or non-thesis option.
Thesis students must complete 23 credits of coursework, 8 credits of thesis research, and a 2 credit research rotation, in addition to writing and defending a thesis. This path is ideal for those interested in working as research scientists or pursuing Ph.D. or M.D. degrees.
The non-thesis option is geared toward those individuals who would like to accelerate their careers in industry but who are not necessarily interested in performing research themselves. Non-thesis students must take 30 credits of coursework and complete a 3 credit capstone writing project.
Students enrolled in the thesis track work side-by-side with research graduate faculty in areas such as drug discovery and development, molecular modeling, chemical synthesis, in vitro and in vivo studies of drug mechanisms and pharmacological actions, pharmacokinetic analysis, and the transport and absorption of nanopharmaceuticals. Recent master's students' projects include:
- Determination of Synergistic Antioxidiant Acitivty of α- and δ- Tocopherylcarbamate Co-drugs on lipid Peroxidation in Skin (Faculty Advisor: Martha Hass, Ph.D.)
- Effect of Hedgehog Signaling Pathway on VDUP1 Expression in Human Embryonal Palatal Mesenchymal (HEPM) and Colon Cancer (HT-29) Cell Lines (Faculty Advisor: Jeffrey Voigt, Ph.D.)
- Molecular Basis of Histone Acetyl-lysine Recognition by the BRPF1 Bromodomain (Faculty Advisor: Karen Glass, Ph.D.)
- Vitamin D3 up-regulated protein 1 (VDUP1) contributes to neural fate specification during Drosophila brain development (Faculty Advisor: Richard Dearborn, Ph.D.)
In Albany, research strengths include drug delivery, drug discovery, bioanalytical technologies, cell signaling, pharmacokinetics, pharmacodynamics, and neuroscience. Students also have access to the College’s Pharmaceutical Research Institute (PRI) which is based in nearby Rensselaer and whose work explores the application of nanotechnology in the areas of drug design and delivery.
At our campus in Colchester, Vermont, faculty research focuses on the field of epigenetics, which explores the field of gene regulation and the mechanisms for manipulating the body’s natural actions and the use of computer modeling to predict how new drug candidates are likely to behave in the body.
Publicis Touchpoint Solutions
Mega LifeSciences Public Company
Albany Molecular Research Inc.
Bassett Healthcare Network
Bristol Meyers Squibb
DAKO-Agilent Pathology Solutions
National Renewable Energy Lab
Truven Health Analysis
Students Enrolled in PhD Programs
The University of Iowa
University of Rochester
University of Toledo
University of Maryland